Printer-friendly versionPDF version
Date and time: 
Fri, 2018-04-13 15:55
Location / Venue: 

Sawela Lodge, Naivasha

The Kenya Obstetrical and Gynaecological Society (KOGS) held its 42nd Annual scientific conference on Feb 21-23rd 2018, at Sawela Lodge, Naivasha. During this conference the department of Obstetrics and Gynaecology, University of Nairobi had a strong presence led by the Chairman Prof. Omondi Ogutu, Prof. Qureshi, Prof. Ndavi, Prof. Cheserem, Dr. Osoti, and Dr. Gwako among others.

The theme for this year’s conference was “Meeting the challenges in reproductive health through impactive training: Guiding the way into the 21st century

It is in this regard that the Champion and ACTION trial teams led by Prof. Zahida Qureshi, Dr. Alfred Osoti and Dr. George Gwako made 3 presentations on 3 key areas of concern in maternal and Childhealth: Post-partum haemorhage(Champion trial), Preterm birth (ACTION trial) and  maternal sepsis (GLOSS study).

(Prof. Zahida Qureshi making a presentation on “ACTION Trials”)

ACTION trials are multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period (ACTION I) and late preterm period (ACTION II) in hospitals in low-resource countries to improve new-born outcomes. The trials will be conducted in Kenya, Nigeria, India, Pakistan and Bangladesh.

In KENYA, the study sites are Coast General referral hospital, Nakuru level 5 hospital, Thika level 5 hospital and Kiambu Level 5 hospital. The trial is scheduled to start in April 2018 and will recruit participants over a two year period.

GLOSS was a WHO global study whose overall aim was to test and validate a new definition for maternal sepsis in 54 countries around the world. Data collected from this study will be used to assess the burden and current management of maternal and early neonatal sepsis which are among the top 5 causes of maternal and neonatal morbidity and mortality globally.

Expiry Date: 
Thu, 2020-04-02 15:55